Search

Background: Prolonged postoperative ileus (PPOI) contributes to morbidity and prolonged hospitalization. Prucalopride, a selective 5-hydroxytryptamine receptor agonist, may enhance bowel motility. This review assesses whether the perioperative use of prucalopride compared to placebo is associated with accelerated return of bowel function post gastrointestinal (GI) surgery. Methods: OVID, CENTRAL, and EMBASE were searched as of January 2024 to identify randomized controlled trials (RCTs) comparing prucalopride and placebo for prevention of PPOI in adult patients undergoing GI surgery. The primary outcomes were time to stool, time to flatus, and time to oral tolerance. The secondary outcomes were incidence of PPOI, length of stay (LOS), postoperative complications, adverse events, and overall costs. The Cochrane risk of bias tool for randomized trials and the Grading of Recommendations, Assessment, Development, and Evaluations framework were used. An inverse variance random effects model was used. Results: From 174 citations, 3 RCTs with 139 patients in each treatment group were included. Patients underwent a variety of GI surgeries. Patients treated with prucalopride had a decreased time to stool (mean difference 36.82 hours, 95% CI 59.4 to 14.24 hours lower, I2 = 62%, low certainty evidence). Other outcomes were not statistically significantly different (very low certainty evidence). Postoperative complications and adverse events could not be meta-analyzed due to heterogeneity; yet individual studies suggested no significant differences (very low certainty evidence). Discussion: Current RCT evidence suggests that prucalopride may enhance postoperative return of bowel function. Larger RCTs assessing patient important outcomes and associated costs are needed before routine use of this agent. [ABSTRACT FROM AUTHOR]

Background: Postoperative gastrointestinal dysfunction (POGD) commonly occurs following gastrointestinal (GI) surgery and is associated with specific anesthetic agents. Cholinesterase inhibitors employed for reversing neuromuscular blockade have been implicated in development of POGD. Sugammadex, a novel reversal agent, is linked with reduced POGD. However, there is a lack of comprehensive comparative review between these agents regarding their impact on POGD following GI surgery. This study aims to systematically review the effects of sugammadex on POGD compared to cholinesterase inhibitors following GI surgery. Methods: MEDLINE, EMBASE, and CENTRAL were searched as of July 2022 to identify articles comparing sugammadex with cholinesterase inhibitors in patients undergoing gastrointestinal surgery, specifically in relation to POGD. Secondary endpoints included length of hospital stay, readmission rates, pulmonary complications, and postoperative morbidity. Results: From 198 citations, 2 randomized controlled trials (RCTs) and 3 retrospective cohorts with 717 patients receiving sugammadex and 812 patients receiving cholinesterase inhibitors were included. Significantly lower rates of prolonged postoperative ileus (OR.44, 95% CI.25-.77, P <.05, I2 = 56%, low certainty evidence) was observed with sugammadex. No significant difference in any other outcome was observed. Narrative review of readmission data demonstrated no significant difference. Conclusion: The use of sugammadex following gastrointestinal surgery is associated with significantly lower rates of prolonged postoperative ileus compared to cholinesterase inhibitors. However, these do not translate into a significant reduction in length of stay, morbidity, or postoperative nausea and vomiting. Results are limited by the numer of studies included and missing data, more robust RCTs are needed before recommendations can be made. [ABSTRACT FROM AUTHOR]

Drug use and road traffic injuries (RTIs) are significant public health concerns globally, with the majority of RTIs occurring in low- and middle-income countries. Driving under the influence of alcohol and drugs is a major factor in RTIs, as psychoactive drugs can impair mental functioning and vehicular control. While alcohol-related traffic deaths have declined, drug-impaired driving is increasing. In India, RTIs are on the rise, and there is a need for more research on drug use and driving under the influence. The lack of research evidence in India contributes to a lack of comprehensive laws and policies for prevention and treatment of drug-related RTIs. It is recommended that research focus on various aspects of drug-impaired driving, and trauma centers should be equipped with testing and treatment services. [Extracted from the article]

With economies and business becoming knowledge intensive, the role of education industry has immensely risen in significance. This has given rise to a highly competitive landscape in higher education, with faculty retention as a major challenge for the institutions leading to negative consequences in terms of education quality, stakeholder satisfaction and rankings. This paper discusses the factors influencing faculty retention in HEIs in India within the framework of Social Exchange Theory. The sub dimensions of HR climate were explored using Principal Components Analysis. The relative importance of sub dimensions in forming the overall climate was estimated and the effect of HR climate on faculty retention was studied with Organizational Commitment and Organizational Trust as mediators employing a hierarchical components model in the PLSSEM analysis. The results indicate that HR climate has a significant positive effect on faculty retention through organizational commitment and organizational trust as partial complementary mediators. Findings have significant theoretical as well as practical implications in extending the present knowledge regarding the subdimensions and effect of HR climate on faculty retention and the suggested measures to be taken in implementing effective HR Management systems in the Higher Education Institutions. [ABSTRACT FROM AUTHOR]

Background: While the pivot shift examination is often regarded as the gold standard test for diagnosis of anterior cruciate ligament (ACL) injury, one of the pitfalls of the pivot shift test is that it lacks standardization among physicians. The PIVOT App is a validated application to quantify the amount of tibial translation during the pivot shift maneuver and improve standardization of clinical measurement. Indications: The PIVOT App can be used in both clinic and operating room settings for patients who sustained injury to the ACL. The PIVOT App may assist in identifying the amount of rotatory knee laxity in patients with ACL deficiency or following ACL reconstruction. Technique Description: The PIVOT App works by quantifying the amount of translation in the lateral tibia relative to a marker on the lateral femoral epicondyle. To use the PIVOT App, 3 yellow circle stickers are placed on the bony prominences of the lateral knee: the lateral epicondyle, Gerdy's tubercle, and the "pivot point" 3 cm posterior to Gerdy's tubercle parallel to the joint line. Once placed, the pivot shift flexion maneuver can be recorded in the PIVOT App and analyzed to identify both the distance of spontaneous tibial reduction during the pivot shift maneuver and the time of reduction in seconds. The most common problems encountered while using the application include (1) improper marker placement, (2) interference of marker tracking with yellow color in the background, (3) interference of marker tracking with overhead lighting, and (4) extraneous data collection before and after pivot shift flexion. Results: Previous studies have validated the PIVOT App to accurately distinguish normal, low-grade, and high-grade pivot shifts with resultant increasing tibial translation in the lateral compartment of the knee. The PIVOT App has been used at institutions worldwide to quantify and standardize measurement of the pivot shift. Conclusion: The PIVOT App is a validated application to quantify the amount of lateral tibial translation and reduction during the pivot shift maneuver. Proper use and avoidance of complications while using the application can aid clinicians in accurate diagnosis of rotatory knee laxity in patients following ACL injury. Patient Consent Disclosure Statement: The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication. [ABSTRACT FROM AUTHOR]